Health
Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19 – News-Medical.Net
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School…
Reviewed by Emily Henderson, B.Sc.Nov 12 2020
In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.
The study, a collaboration between the university’s Department of Psychiatry and…
-
Business15 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General13 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
General23 hours agoAustralia solved civilisation’s problems
-
Business20 hours agoThis artificial intelligence (AI) stock will be the Nvidia of quantum computing by 2035